-- （更新內容包括該藥物的主要研發方武漢益智生物製藥） 武漢益智生物製藥（港交所代號：2496）與中國生物製藥（港交所代號：1177）旗下子公司共同研發的藥物M701的新藥申請已獲中國國家藥品監督管理局受理。 根據週四在香港交易所提交的兩份文件顯示，該藥物用於治療晚期上皮惡性腫瘤引起的惡性腹水。 中國生物製藥旗下子公司正泰天青藥業集團於2024年8月獲得該藥物在中國大陸的獨家可轉授許可，負責該藥物的註冊、研發、生產和銷售。
Related Articles
Australia
Max Resource Applies for OTCQB Listing; Shares Down 8.2%
Max Resource (MAX.V) on Thursday said it applied to list its shares on the U.S. OTCQB market.The company's shares will continue to trade on the Toronto Stock Exchange Venture under it current symbol, it said.The company's OTCQB application is subject to OTC Markets' review and approval.The company's shares are eligible for settlement through the Depository Trust Company (DTC), which facilitates the electronic clearing and settlement of publicly traded companies in the United States, the company added."We believe that uplisting on the OTCQB would expand Max's exposure to U.S. investors, increase trading accessibility and liquidity, and support the company's efforts to build a broader international shareholder base as the exploration season advances into full swing," said chief executive Brett Matich.The company's shares were last seen down $0.025 at $0.28 on the TSX Venture Exchange.Price: $0.28, Change: $-0.03, Percent Change: -8.20%
$MAX.V
Australia
Macquarie Downgrades PayPal to Neutral From Outperform, Price Target is $50
PayPal (PYPL) has an average rating of hold and mean price target of $50.09, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $46.94, Change: $+0.68, Percent Change: +1.46%
$PYPL
Australia
Fortinet Set for Faster Growth on Cyber Risk, AI Upgrades, Wedbush Says
Fortinet (FTNT) is positioned for stronger growth as AI-driven infrastructure needs, rising cyber risks, product upgrades, vendor consolidation, and improving sales momentum support its revenue and billings outlook, Wedbush Securities said Thursday in a report.Q1 billings rose 31% to $2.09 billion, above Wall Street estimates, with strength across security operations and operational technology security, the report said. Revenue climbed 20%, helped by large customers upgrading to higher-performance systems for AI-related workloads, Wedbush said.Operating margins and earnings per share both exceeded expectations on strong execution and cost control, Wedbush said. Fortinet raised its 2026 revenue and billings outlook as cyber threats, data security needs, and cost pressures push customers toward broader cyber platforms, the report said.Wedbush raised its price target on Fortinet stock to $125 from $90 and maintained its outperform rating, citing greater confidence in the company's growth recovery.Price: $110.88, Change: $+20.93, Percent Change: +23.27%
$FTNT